NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Tatva Chintan Pharma Chem Limi

BSE: 543321 22 Feb 2025
Commodities
₹ 682.0
Tatva Chintan Pharma Chem Limited specializes in Specialty Chemicals within the Commodities sector.

Tatva Chintan Pharma Chem Limi - Share Price & Details

Market Cap
₹1,595
High /Low
1,320 / 645.0
Stock P/E
112.0
Book Value
₹315.0
Dividend Yield
0.29
ROCE
7.02
ROE
₹4.86
Face Value
10.0
PEG Ratio
12.7
EVEBITDA
₹34.0
Debt
15.2
CMP / FCF
-17.4
Debt to equity
₹0.02
NP Ann
30.4
High price all time
2,978
Piotroski score
₹6.0
Graham Number
208.0
No. Eq. Shares
2.34
Net CF
₹7.94
Net profit
14.3
Price to book value
2.16
Interest Coverage
₹18.3
Low price all time
645.0
Industry PE
30.0
Reserves
₹714
Free Cash Flow
₹-30.3

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Southern Gas Ltd.,90.44166.980.03
Indo Gulf Industries Ltd.,611.192.37
Tatva Chintan Pharma Chem Limi858.960.06112.0
GOCL Corporation Limited1381.9718.6410.5
India Pesticides Limited1722.21.5125.2

Peer Comparison Chart


About Tatva Chintan Pharma Chem Limi

Tatva Chintan Pharma Chem Limited, with Security Code 543321, is a leading player in the Specialty Chemicals industry, categorized under the Commodities sector, offering Equity instruments.


Latest News

Tatva Chintan Pharma Chem Gains 9.59% on January 3, 2025, Outperforming Sector

(02 Jan 2025)
Tatva Chintan Pharma Chem, a small-cap player in the chemicals industry, experienced a notable gain of 9.59% on January 3, 2025.
Read more →

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Senior Key Executive Ajaykumar Patel is the most upbeat insider, and their holdings increased by 11% last week

(29 Nov 2024)
Key Insights Significant insider control over Tatva Chintan Pharma Chem implies vested interests in company growth The...
Read more →

IPO listing: Kronox Lab Sciences share price debuts at ₹165, a 21% premium to issue price

(21 Nov 2024)
Kronox Lab Sciences share price had a strong debut on the stock exchanges with a 21% premium to the issue price. The IPO was oversubscribed by 117.25 times,...
Read more →

Nazara Tech, Sadbhav Engineering among 10 cos that saw highest drop in mutual fund holdings in Sept

(09 Nov 2024)
The mutual fund holding in this stock decreased by 3.84% on a month-on-month basis. The holding in September was 6.76% against 10.60% in...
Read more →

Tatva Chintan Pharma Chem's Stock Sees 7.45% Increase, Outperforms Sector by 7.35%

(07 Nov 2024)
Tatva Chintan Pharma Chem, a smallcap company in the chemicals industry, saw a 7.45% increase in its stock price on November 7, 2024.
Read more →

Phase Transfer Catalyst Market Next Big Thing| Major Giants Tatva Chintan Pharma Chem, Central Drug House, Solvay

(07 Nov 2024)
Press release - DiMarket - Phase Transfer Catalyst Market Next Big Thing| Major Giants Tatva Chintan Pharma Chem, Central Drug House,...
Read more →